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Candida parapsilosis is the Candida species isolated the secondmost frequently from blood cultures in South America and some
European countries, such as Spain. Since 2005, this species has been considered a complex of 3 closely related species: C. parapsi-
losis, Candida metapsilosis, and Candida orthopsilosis. Here, we describe a real-time TaqMan-MGB PCR assay, using mitochon-
drial DNA (mtDNA) as the target, which readily distinguishes these 3 species. We first used comparative genomics to locate syn-
tenic regions between these 3 mitochondrial genomes and then selectedNADH5 as the target for the real-time PCR assay. Probes
were designed to include a combination of different single-nucleotide polymorphisms that are able to differentiate each species
within the C. parapsilosis complex. This newmethodology was first tested using mtDNA and then genomic DNA from 4 refer-
ence and 5 clinical strains. For assay validation, a total of 96 clinical isolates and 4 American Type Culture Collection (ATCC)
isolates previously identified by internal transcribed spacer (ITS) ribosomal DNA (rDNA) sequencing were tested. Real-time
PCR using genomic DNAwas able to differentiate the 3 species with 100% accuracy. No amplification was observed when DNA
from other species was used as the template. We observed 100% congruence with ITS rDNA sequencing identification, including
for 30 strains used in blind testing. This novel method allows a quick and accurate intracomplex identification of C. parapsilosis
and saves time compared with sequencing, which so far has been considered the “gold standard” for Candida yeast identifica-
tion. In addition, this assay provides a useful tool for epidemiological and clinical studies of these emergent species.
Candida albicans remains the most prevalent species in humansuperficial and invasive Candida infections, although there is
concern over the increasing rates of non-C. albicans infections
worldwide (2, 18). C. parapsilosis is a relevant pathogen primarily
in SouthAmerica, where it causes from 19% to 38%of all episodes
of candidemia (6, 25, 26). Similarly, data byAlmirante et al. (2005)
andCanton et al. (2011) show thatC. parapsilosis causes from15%
to 23% of all hematogenous candidiasis cases in Spanish hospitals
(1, 4).
Recently, the genetically heterogeneous taxon C. parapsilosis
was reclassified into 3 species:Candida parapsilosis (sensu stricto),
Candida orthopsilosis, and Candida metapsilosis (30). Although
the epidemiological and clinical differences caused by these Can-
dida species have not yet been fully determined, several in vitro
studies have demonstrated biological differences between them,
including th
e expression of virulence factors, susceptibility to antifungal
agents, and geographical distribution (3, 10, 12, 13, 22, 24).
Currently, species identification within the C. parapsilosis
complex is based on DNA techniques such as randomly amplified
polymorphic DNA analysis, restriction fragment length polymor-
phism analysis of the SADH locus, and sequencing of the internal
transcribed spacer (ITS) (13, 20, 31). These methods are time-
consuming and labor-intensive and, with the exception of DNA
sequencing, may have accuracy and reproducibility limitations
(23, 27).
Because mutation rates in the mitochondrial genome are
higher than those in the nuclear genome, it is possible to obtain
sufficient resolution to distinguish close phylogenetic relation-
ships (5). Indeed, our group has shown that mitochondrial DNA
(mtDNA) sequences can be readily used to discriminate Candida
glabrata isolates. Analysis of the cytochrome c oxidase subunit 2
(COX2) enables typing of C. glabrata and clustering of strains in
association with their geographical origins (28).
In the present study, we describe a specific, fast, sensitive, and
accurate real-time PCR method based on mtDNA-specific target
detection that is capable of discriminating all 3 species within the
C. parapsilosis complex.
MATERIALS AND METHODS
Microorganisms. A total of 100 C. parapsilosis (sensu lato) strains were
used to validate our assay: (i) four reference strains obtained from the
American Type Culture Collection (ATCC),C. parapsilosis (sensu stricto)
ATCC 22019 and ATCC 90018, C. orthopsilosis ATCC 96141, and C.
metapsilosis ATCC 96143; (ii) a panel of 66 clinical isolates obtained from
different body sites and geographical regions of Brazil previously identi-
fied to the species level by sequencing of the ITS region (part of this
collection had already been deposited in GenBank [NCBI]) (13); and (iii)
a group of 30 well-characterized C. parapsilosis (sensu lato) clinical iso-
lates that were kindly provided in a blind fashion by G. Quindós (Bilbao,
Spain) (see Table S1 in the supplemental material) (24). In addition, the
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reference strains C. albicans (ATCC 90029), Candida tropicalis (ATCC
750), C. glabrata (ATCC 90030), Candida lusitaniae (ATCC 66035), Can-
dida krusei (ATCC6258), and Lodderomyces elongisporus (CBS 2605) were
also tested as controls. Tests for viability, purity, and phenotypic identifi-
cation of the samples were performed as previously described (13).
Microorganism identification using amplification and sequencing
of ITS region of ribosomal DNA. The genomic DNA was extracted from
single colonies using glass beads (19). Amplification and sequencing were
performed with the universal primers ITS1 and ITS4 (Table 1) (32). PCR
and sequencing were performed as previously described by our group
(14).
In silico selection of the mtDNA target gene for species identifica-
tion.Complete mitochondrial genome sequences from 3Candida species
were retrieved fromGenBank (NCBI):C. parapsilosisCBS7157 (accession
number X74411), C. parapsilosis CLIB214 (accession number
DQ026513), C. orthopsilosis MCO456 (accession number AY962590), C.
orthopsilosis MCO471 (accession number DQ026513), C. metapsilosis
MCO448 (accession number NC006971), and C. metapsilosis PL448 (ac-
cession number AY391853). We generated a whole-genome alignment
using the Progressive Mauve algorithm in the MAUVE program (7) to
verify the synteny. Selected sequences were aligned using the Seaview pro-
gram (version 4) (16).
Extraction and amplification of Candida yeast mitochondrial DNA
for verification of single-nucleotide polymorphism (SNP) presence on
the target gene.Mitochondrial DNA was isolated as described elsewhere
with a yield of 100 ng/l (8). A 620-bp fragment ofmitochondrialNADH5
was amplified and sequenced with specific primers (Table 1). PCR (25l)
was performed using the MasterMix protocol (Promega, Madison, WI).
The conditions of PCR cycles were 3 min at 95°C, followed by 40 cycles at
95°C for 45 s, 52°C for 45 s, and 1 min at 72°C and by a final 5-min
extension at 72°C.
PCR products were purified using an AmiconUltra-0.5 kit (Millipore,
MA) and sequenced in an ABI3100 automated sequencer (Applied Bio-
systems). Phred-Phrap-Consed were used for the assembly and finishing
of high-quality sequences (Phred scores,40) (9, 15). Species were iden-
tified by use of the Basic Local Alignment Search Tool (BLAST) with an E
value of105 as the cutoff.
Identification ofC. parapsilosis (sensu stricto),C. orthopsilosis, and
C. metapsilosis strains by real-time PCR. (i) Primer and probe design.
Primers and probes specific for the NADH5 gene were designed using
Primer Express software (Applied Biosystems). Sequences and character-
istics of the primers and probes are shown in Table 1.
(ii) Real-time PCR assay. Real-time PCR was performed in a
StepOnePlus real-time PCR system (Applied Biosystems). The reaction
mix contained 12.5 l of TaqMan universal PCR master mix (Applied
Biosystems), 400 nM each primer, 250 nM probe, and 160 ng of genomic
DNA (or 40 ng of mtDNA) from the different tested strains in a final
volume of 25 l. A single-color simplex assay was used, in which each
probe was added to different reaction tubes. Real-time PCR conditions
were as follows: initial denaturation at 50°C for 2 min and 95°C for 10
min, 40 cycles of 95°C for 15 s and 51°C for 30 s, and a final elongation step
of 1 min at 60°C. Fluorescence was measured for 1 min during the elon-
gation step. The assay sensitivity was estimated by comparing the real-
time identification results with the identification by ITS sequencing. To
ensure the specificity of the assay, we used genomic DNA from L. elongis-
porus and different Candida species (C. albicans, C. tropicalis, C. glabrata,
C. lusitaniae, and C. krusei) as the templates in the reaction.
Nucleotide sequence accessionnumbers.The sequences generated in
this study have been deposited in the GenBank (NCBI) database (http:
//www.ncbi.nlm.nih.gov/GenBank) under the following accession num-
bers: JQ963283, JQ963277, JQ952736, JQ952738, JQ952737, JQ952741,
JQ963282, JQ952736, JQ952739, JQ952740, JQ952742, JQ963278,
JQ963280, JQ963281, JQ963279, JN989516, JN989528, JN989517,
JN989529, JN989518, JN989530, JN989519, JN989531, JN989532,
JN989533, JN989520, JN989534, JN989535, JN989521, JN989522,
JN989536, JN997459, JN989523, JN989524, JN989537, JN989525,
JN989526, JQ963284, JN989527, JQ963285, JN989507, JN989508,
JN989509, JN989510, JN989511, JN989498, JN989499, JN980098,
JN980099, JN980100, JN989496, JN989500, JN989502, JN989503,
JN989505, JN989512, JN989506, JN989501, JN989497, JN989504,
JN585704, JQ585706, JQ585705, JQ585713, JQ585709, JQ585711,
JQ585710, JQ585707, JQ585714, JN989513, JN989514, JN989515, and
JQ585715.
RESULTS
Molecular identification by sequencing of the ITS region of all
clinical isolates (66 Brazilian and 30 Spanish strains). The
strainswere initially identified asC. parapsilosis (sensu lato) on the
basis of their micromorphology characteristics and biochemical
profiles using the ID32C system (bioMérieux, Marcy l=Etoile,
France) (data not shown). ITS sequencing was used as the “gold
standard” for the identification to the species level of all clinical
strains tested. The amplicon lengths of the ITS regionswere 593 bp
to 612 bp, and sequences generated were used in BLAST searches
(http://www.ncbi.nlm.nih.gov) to confirm the preliminary iden-
tifications. BLAST analysis with the ITS sequences was capable of
identifying all reference and clinical strains as follows: 50 isolates
were identified asC. parapsilosis (sensu stricto), 40 were identified
as C. orthopsilosis, and 10 were identified as C. metapsilosis.
In silico analysis. In silico analysis showed that the mitochon-
drial genomes of C. parapsilosis (sensu stricto), C. orthopsilosis,
and C. metapsilosis are syntenic. The criterion for selecting the
TABLE 1 Oligonucleotide primers and probes sequences used in this study
Oligonucleotidea Sequence 5= to 3=
Modificationb
Purpose5= end 3= end
ITS1c TCCGTAGGTGAACCTGCGG None None ITS sequencing
ITS4c GCATATCAATAAGCGGA None None ITS sequencing
NADH5 F GTGCTGGTTCTGTTATTCATAG None None NADH5 sequencing
NADH5 R GCCAGAGTCTACCATTAACCTAC None None NADH5 sequencing
RT-NADH5 F CATATACATGAAAATATACGTATG None None Real-time PCR
RT-NADH5 R CATTATCTCTATTAAATCCAATAA None None Real-time PCR
Cp NADH5 TTCCTATGATTATATTAGTTATCTAT FAM MGB C. parapsilosis NADH5 probe
Co NADH5 TACCTATGGTAATATTAGTAATATAT VIC MGB C. orthopsilosis NADH5 probe
Cm NADH5 TACCTATGGTTATTTTAGTAATTTAT NED MGB C. metapsilosis NADH5 probe
a The letters F and R in the primer names describe the orientation of the primer 5= to 3=: F for forward (sense) and R for reverse (antisense).
b FAM, 6-carboxyfluorescein.
c White et al. (17).
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target gene was to find regions with different SNP profiles that
were capable of discriminating the 3 species and that were flanked
by conserved sequences in the same region of the chromosome.
On the basis of the alignments from the 6 mitochondrial whole-
genome sequences, we selectedNADH5 as the target for real-time
PCR. The pairwise uncorrected distances between three species
for the complete sequence were 5.10% for C. parapsilosis (sensu
stricto) and C. metapsilosis, 4.85% for C. parapsilosis (sensu
stricto) and C. orthopsilosis, and 5.16% for C. metapsilosis and C.
orthopsilosis. SNPs identified in silico were confirmed by sequenc-
ing 620 bp of NADH5 of the 4 reference strains and 6 clinical
isolates (LEMI6492, LEMI6814, LEMI7685, LEMI8521,
LEMI7787, LEMI7518) (Fig. 1). The partial sequences ofC. parap-
silosis (sensu stricto) and C. metapsilosis showed 100% sequence
similarity with each of the control strains. Strain LEMI7518, iden-
tified as C. orthopsilosis, has seven nucleotide differences from the
reference strain, with one nucleotide difference being inside the
probe region (Fig. 1).
Molecular identification by real-time PCR. Primers were de-
signed to be specific for the C. parapsilosis species complex and to
anneal to a highly conserved region of NADH5. Three different
specific probes (TaqMan-MGB) targeting a region of NADH5
were designed for the 3 species within the C. parapsilosis complex.
Initially, the ability of each probe to specifically identify its target
was assessed using mtDNA from 4 reference strains and 5 clinical
isolates (LEMI7294, LEMI6492, LEMI3523, LEMI3494,
LEMI8521) as the template. Different annealing temperatures,
probe concentrations, and mtDNA concentrations were tested to
ensure specificity and good reproducibility (data not shown) of
the PCR assay, and the best performancewas obtained using 51°C,
250 nM, and 40 ng/reaction mixture, respectively. The assay was
determined to be species specific because (i) all strains tested were
correctly identified, (ii) nonspecific amplification was not ob-
served, and (iii) no cross-species probe signal was observed.
To show that we obtain identical results using either purified
mtDNA or total cellular DNA, we compared the specificity and
sensitivity of the method using total DNA from reference strains
as the template. We used the same annealing temperature and
probe concentrations established for themtDNA assays. Different
genomicDNA concentrations were tested (data not shown), and a
concentration of 160 ng/reaction mixture was selected. Similar to
the mtDNA analysis, the probes were very specific at the species
level, and all strains tested were correctly identified.
After the standardization of the real-time PCR assay, we ap-
plied this method to analyze the genomic DNA of all the clinical
isolates from Brazil included in this study (n 66). By real-time
PCR, we identified 37 as C. parapsilosis (sensu stricto), 24 as C.
orthopsilosis, and 5 as C. metapsilosis. The results generated by
real-time PCR showed 100% concordance with the results ob-
tained by ITS sequencing (Table 2). In addition, all isolates from
G. Quindós tested in a blinded fashion (n  30) were correctly
identified as the following: 21 C. parapsilosis (sensu stricto), 5 C.
orthopsilosis, and 4 C. metapsilosis. The Spanish strains were orig-
inally identified in G. Quindós’s lab by ITS sequencing (24).
FIG 1 Local alignment of theNADH5 gene. Primer regions are shown in boxes (forward primer from 223 to 246 bp; reverse primer from 284 to 307 bp), and the
probe region (from 251 to 276 bp) is in the dashed box. The SNP between the C. orthopsilosis strains located in the probe region is at position 270 bp. Cp, C.
parapsilosis (sensu stricto); Cm, C. metapsilosis; Co, C. orthopsilosis.
TABLE 2 Comparison of the identification of C. parapsilosis species
complex isolates by ITS sequencing and the real-time PCR assay
Strain group and
species identified by
ITS sequencing (no.
of isolates tested)
No. of isolates identified by real-time PCR assay
%
agreementa
C. parapsilosis
(sensu stricto) C. orthopsilosis C. metapsilosis
Reference strains (4) 100
C. parapsilosis
(sensu stricto)
(2)
2 0 0
C. orthopsilosis (1) 0 1 0
C. metapsilosis (1) 0 0 1
Clinical isolates (66) 100
C. parapsilosis
(sensu stricto)
(27)
27 0 0
C. orthopsilosis
(34)
0 34 0
C. metapsilosis (5) 0 0 5
Blinded strains (30) 100
C. parapsilosis
(sensu stricto)
(21)
21 0 0
C. orthopsilosis (5) 0 5 0
C. metapsilosis (4) 0 0 4
Control strains (5) NAb
C. albicans (1) 0 0 0
C. tropicalis (1) 0 0 0
C. krusei (1) 0 0 0
C. glabrata (1) 0 0 0
C. lusitaniae (1) 0 0 0
L. elongisporus (1) 0 0 0
a Agreement analysis was performed between the real-time PCR assay described in the
current study and the “gold standard” technique (ITS sequencing).
b NA, not applicable.
Souza et al.
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DISCUSSION
In the present study, we describe a rapid and accurate method
using mtDNA and TaqMan technology for identification of the 3
species within the C. parapsilosis complex. We decided to use
mtDNA because it has been recognized to be a valuable target for
evaluating close phylogenetic relationships because of its higher
rate of mutation than nuclear DNA (5, 28, 33). To explore the
potential of mtDNA for species identification, we first performed
an in silico analysis to check for possible polymorphic regions
capable of differentiating the 3 target species within the C. parap-
silosis complex. After checking thewholemtDNA sequences of the
3 species, we found polymorphic regions within theNADH5 gene,
which were chosen as targets for real-time PCR. The pairwise dis-
tances of NADH5 homologs are well balanced between the three
pair groups and are higher than those found for ITS and COX3 in
the C. parapsilosis complex and for COX2 in C. glabrata (28, 30).
The probes were designed to include a combination of differ-
ent SNPs able to differentiate each species within the C. parapsi-
losis complex (Fig. 1). The large adenine and thymine content in
mtDNA as a whole and, consequently, in the selected region im-
pairs the design of probes with high annealing temperatures. This
problemwas solved using the TaqMan-MGB, which enhances the
melting temperature of probes.
Despite all the progress obtaining specific probes based on
mtDNA that has been made, we considered the protocol for its
extraction to be time-consuming and labor-intensive (8). There-
fore, we showed that during the genomic DNA extraction from
yeast cells, some mtDNA is also obtained, making it possible to
run the PCR assays on extracted total DNA and still correctly
identify all strains (Table 2). Consequently, the new assay becomes
more suitable for clinical laboratories.
In the present study, we tested 100 C. parapsilosis (sensu lato)
strains and a control group of 6 other species (Table 2). Because all
C. parapsilosis (sensu lato) strains were correctly identified, we
have established that the primer and probe sets exhibited 100%
specificity, with no background fluorescence detected within the
species of the complex.No amplificationwas observedwhenDNA
fromother species was used as the template, including theDNAof
L. elongisporus, which is biochemically indistinguishable from the
C. parapsilosis species complex (21). Finally, we observed 100%
concordance with the ITS sequencing identification, including for
the 30 strains used for blind testing.
Recently, some authors proposed new identification assays to
distinguish these closely related species. In 2011, Hays et al. de-
scribed a real-time PCR assay using melting curve analysis on a
portion of the SADH gene. This method provides a rapid identi-
fication; however, the assay may exhibit low reproducibility be-
cause it is possible to observe variations in themelting curve when
different thermocyclers are used (17). Garcia-Effron et al. (11)
proposed a new real-time PCR assay that can differentiate these 3
species using themolecular beacon technology and the ITS region
as the target. This assay was highly specific, exhibited good repro-
ducibility, and showed that theC. parapsilosis species complex can
be identified quickly, thus demonstrating its suitability for clinical
applications (11). Santos et al. (29) developed an assay using ma-
trix-assisted laser desorption ionization–time of flight intact cell
mass spectrometry (MALDI-TOF ICMS) for identification of
some emerging pathogenic Candida species. These authors have
shown that this method identifies the 3 species within the C.
parapsilosis complex; however, a quality-controlled databasemust
be available to provide an accurate analysis (29). In all methods
described above, only limited numbers of C. metapsilosis isolates
(1, 6, and 2, respectively) were tested by the authors (11, 17, 29). In
our analysis, we were able to validate our strategy by testing 50
strains of C. parapsilosis (sensu stricto), 40 strains of C. orthopsi-
losis, and 10 strains of C. metapsilosis, including strains from 2
different countries.
In conclusion, we found an unexpected high variability in
NADH5, a gene that encodes a respiratory chain protein and
therefore that is expected to be under strong negative selection.
Nevertheless, we described a level of variability whose analysis
reveals that it can be exploited for epidemiological purposes. Our
data show that the variability described in our study is sufficient to
unequivocally distinguish the three species of the C. parapsilosis
complex. We were able to validate a real-time PCR assay using
mtDNA as the template. This new identification method allows
the C. parapsilosis species complex to be identified quickly and
accurately and saves time compared with conventional sequenc-
ing, which has been considered the gold standard for yeast iden-
tification. In addition, this assay provides a useful tool for epide-
miological and clinical studies of these emergent species.
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